Gliclazide modified release: Its place in the therapeutic Armamentarium
Authors:
- Paola FiorettoPFPaola Fioretto
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Metabolism
- Vol. 49 (10) , 21-25
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- The Use of Sulphonylureas in the ElderlyDrugs & Aging, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- GlimepirideDrugs, 1998
- Glimepiride, a New Once-Daily Sulfonylurea: A double-blind placebo-controlled study of NIDDM patientsDiabetes Care, 1996
- Pharmacokinetics and Pharmacodynamics of the Hydroxy-Metabolite of Glimepiride (Amaryl®) After Intravenous AdministrationDrug Metabolism and Drug Interactions, 1996
- GliclazideDrugs, 1993
- Pathogenesis of diabetic microangiopathy: An overviewThe American Journal of Medicine, 1991
- An evaluation of long-term glycemic control in non-insulin-dependent diabetes mellitus: The relevance of glycated hemoglobinThe American Journal of Medicine, 1991
- The metabolism of gliclazide in manXenobiotica, 1985